254 related articles for article (PubMed ID: 28153080)
1. Stevens-Johnson syndrome and toxic epidermal necrolysis.
Eginli A; Shah K; Watkins C; Krishnaswamy G
Ann Allergy Asthma Immunol; 2017 Feb; 118(2):143-147. PubMed ID: 28153080
[No Abstract] [Full Text] [Related]
2. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
[TBL] [Abstract][Full Text] [Related]
3. Pediatric Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Halted by Etanercept.
Gavigan GM; Kanigsberg ND; Ramien ML
J Cutan Med Surg; 2018; 22(5):514-515. PubMed ID: 29421925
[TBL] [Abstract][Full Text] [Related]
4. Toxic epidermal necrolysis.
Stabenow DL
Postgrad Med; 1972 Dec; 52(6):89-92. PubMed ID: 4635614
[No Abstract] [Full Text] [Related]
5. [Stevens-Johnson syndrome and toxic epidermal necrolysis].
Kaur-Knudsen D; Zachariae C; Thomsen SF
Ugeskr Laeger; 2013 Dec; 175(50):3096-9. PubMed ID: 24629532
[TBL] [Abstract][Full Text] [Related]
6. Development of toxic epidermal necrolysis in a coronavirus disease 2019 patient with recurrence of positive SARS-CoV-2 viral RNA.
Tanaka A; Isei M; Kikuzawa C; Hinogami H; Nishida K; Gohma I; Ogawa Y
J Dermatol; 2021 Mar; 48(3):e144-e145. PubMed ID: 33439527
[No Abstract] [Full Text] [Related]
7. Toxic epidermal necrolysis in Stevens--Johnson syndrome.
Assaad D; From L; Ricciatti D; Shapero H
Can Med Assoc J; 1978 Jan; 118(2):154-6. PubMed ID: 757383
[TBL] [Abstract][Full Text] [Related]
8. Pentoxyfylline in toxic epidermal necrolysis and Stevens-Johnson syndrome.
Sanclemente G; De la Roche CA; Escobar CE; Falabella R
Int J Dermatol; 1999 Nov; 38(11):878-9. PubMed ID: 10583942
[No Abstract] [Full Text] [Related]
9. Possible role of TH17 cells in the pathogenesis of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Teraki Y; Kawabe M; Izaki S
J Allergy Clin Immunol; 2013 Mar; 131(3):907-9. PubMed ID: 23083672
[No Abstract] [Full Text] [Related]
10. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
[TBL] [Abstract][Full Text] [Related]
11. Apoptotic cell death in toxic epidermal necrolysis: the Fas ligand assumption.
Gravante G; Esposito G; Filingeri V; Delogu D; Castrì F; Montone A
Arch Dermatol Res; 2006 Mar; 297(9):430-1; author reply 432. PubMed ID: 16429298
[No Abstract] [Full Text] [Related]
12. Stevens-Johnson syndrome and toxic epidermal necrolysis.
Borchers AT; Lee JL; Naguwa SM; Cheema GS; Gershwin ME
Autoimmun Rev; 2008 Sep; 7(8):598-605. PubMed ID: 18603022
[TBL] [Abstract][Full Text] [Related]
13. The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Mockenhaupt M
Expert Rev Clin Immunol; 2011 Nov; 7(6):803-13; quiz 814-5. PubMed ID: 22014021
[TBL] [Abstract][Full Text] [Related]
14. Case of toxic epidermal necrolysis in immunocompromised patient possibly due to Streptococcus pneumoniae serotype uncovered by vaccine.
Kondo M; Suzuki K; Nakayama Y; Matsushima Y; Mizutani K; Habe K; Imai H; Yamanaka K
J Dermatol; 2020 Apr; 47(4):e106-e107. PubMed ID: 32056278
[No Abstract] [Full Text] [Related]
15. Stevens-Johnson syndrome and toxic epidermal necrolysis.
Prendiville J
Adv Dermatol; 2002; 18():151-73. PubMed ID: 12528405
[No Abstract] [Full Text] [Related]
16. Reciprocal contribution of Th17 and regulatory T cells in severe drug allergy.
Hashizume H; Fujiyama T; Tokura Y
J Dermatol Sci; 2016 Feb; 81(2):131-4. PubMed ID: 26596217
[No Abstract] [Full Text] [Related]
17. Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in a NSCLC patient treated with afatinib.
Nühnen VP; Schön MP; Mössner R
J Dtsch Dermatol Ges; 2018 Feb; 16(2):199-201. PubMed ID: 29328518
[No Abstract] [Full Text] [Related]
18. Minimal clinically important differences for measures of treatment efficacy in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Kim WB; Worley B; Holmes J; Phillips EJ; Beecker J
J Am Acad Dermatol; 2018 Dec; 79(6):1150-1152. PubMed ID: 29890189
[No Abstract] [Full Text] [Related]
19. Clues to pathogenesis of toxic epidermal necrolysis.
Merot Y; Saurat JH
Int J Dermatol; 1985 Apr; 24(3):165-8. PubMed ID: 3888879
[No Abstract] [Full Text] [Related]
20. Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Khalili B; Bahna SL
Ann Allergy Asthma Immunol; 2006 Sep; 97(3):272-80; quiz 281-3, 320. PubMed ID: 17042130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
